Please assess the completion status of the following clinical trial:

Trial Title: Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After Conization

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women over 18 years~* CIN 2 or 3 diagnosis at inclusion confirmed for a CIN3 diagnosis by conization.~* HPV detected by Hybrid Capture 2 or RLA genotyping.~* Informed and signed consent by the patient and the investigator~* Coverage by French social security~Exclusion Criteria:~* Pregnancy at the time of inclusion.~* Previous history conization.~* Atypical endometrial or glandular cells or evidence of carcinoma on conization.~* Previous vaccination with a prophylactic HPV vaccine.~* Active viral infections including HIV.~* Acquired or congenital immunodeficiency.~* Long term treatment by corticosteroids or immunosuppressive drugs.~* Persons under protection of law.~* Patients unable to meet the requirements of the protocol.~* Any condition that, according to the investigator, would prevent participation in the study or interfere with the objectives of the study (refusal of supervision at the University Hospital, expected change of address within 3 years, etc)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Women with CIN3 treated by conization (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).